Why the study?
What is the prevalence of familial lipoprotein disorders in patients with premature coronary artery disease?
Population
102 kindreds in whom the proband had significant coronary artery disease documented by angiography before…
Design
Cross-sectional
Authors
Loading...
Supports targeted lipid evaluation in premature CAD; leaves open whether identifying familial disorders improves outcomes.
What is the prevalence of familial lipoprotein disorders in patients with premature coronary artery disease?
More than half of patients with premature CAD have a familial lipoprotein disorder, highlighting the importance of comprehensive lipid screening in this population.
Genest et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: